As many as 149,000 jobs could be lost in the U.S. in the next 10 years without changes to federal policies to support pharmaceutical innovation, PhRMA said in a report. "In order to make progress, we need a policy framework that supports the long and uncertain process of developing treatments by sustaining a robust research enterprise that encourages innovators to take risks and accept the inevitable scientific setbacks," PhRMA spokeswoman Jenni Brewer said. "Public policies need to recognize these investments in order to encourage continued innovation for patients."

Related Summaries